CNR Institutional Research Information System

CUSIMANO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.651
NA - Nord America 1.268
EU - Europa 657
SA - Sud America 324
Continente sconosciuto - Info sul continente non disponibili 33
AF - Africa 29
OC - Oceania 2
Totale 3.964
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.179
SG - Singapore 661
CN - Cina 398
IT - Italia 266
BR - Brasile 254
HK - Hong Kong 173
VN - Vietnam 145
NL - Olanda 111
FR - Francia 99
KR - Corea 59
BD - Bangladesh 52
GB - Regno Unito 50
JP - Giappone 49
IN - India 39
CA - Canada 37
DE - Germania 25
AR - Argentina 24
MX - Messico 22
FI - Finlandia 20
CO - Colombia 17
ES - Italia 17
ID - Indonesia 12
ZA - Sudafrica 12
PL - Polonia 11
EC - Ecuador 10
JM - Giamaica 10
RU - Federazione Russa 9
CR - Costa Rica 8
AT - Austria 7
IL - Israele 7
IQ - Iraq 7
TR - Turchia 7
KE - Kenya 6
SE - Svezia 6
LT - Lituania 5
UY - Uruguay 5
VE - Venezuela 5
HU - Ungheria 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
UA - Ucraina 4
CY - Cipro 3
EG - Egitto 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
PT - Portogallo 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
MY - Malesia 2
OM - Oman 2
PK - Pakistan 2
PS - Palestinian Territory 2
RE - Reunion 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
IE - Irlanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MG - Madagascar 1
MM - Myanmar 1
NO - Norvegia 1
NR - Nauru 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
TG - Togo 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 3.932
Salva come PNG Salva come JPEG
Città #
Singapore 407
Santa Clara 314
Hong Kong 170
Hefei 138
San Jose 123
Beijing 90
Ashburn 74
Lauterbourg 69
Ho Chi Minh City 57
Seoul 57
Los Angeles 44
Tokyo 38
Dallas 36
Hanoi 29
New York 26
Buffalo 23
São Paulo 21
Milan 19
Palermo 17
Naples 14
Houston 13
Helsinki 12
Mumbai 12
Toronto 12
Council Bluffs 11
Mexico City 11
Orem 11
Boardman 10
Brasília 9
Brooklyn 9
Cagliari 9
Denver 9
Frankfurt am Main 9
Montreal 9
Amsterdam 8
Pescara 8
Portsmouth 8
Rio de Janeiro 8
Warsaw 8
Atlanta 7
Bengaluru 7
Chicago 7
Minamishinagawa 7
Phoenix 7
Chennai 6
City of London 6
Kensington 6
Kingston 6
London 6
Vienna 6
Dhaka 5
Elk Grove Village 5
Johannesburg 5
Lappeenranta 5
Nairobi 5
Philadelphia 5
Poplar 5
Potenza 5
San José 5
Stockholm 5
Ankara 4
Bắc Ninh 4
Casandrino 4
Catania 4
Da Nang 4
Guayaquil 4
Lima 4
Lucca 4
Madrid 4
Marigliano 4
Messina 4
Miami 4
Montevideo 4
Newark 4
Ninh Bình 4
Nuremberg 4
Paris 4
Rome 4
Roubaix 4
The Bronx 4
Xiamen 4
Asunción 3
Belo Horizonte 3
Bogotá 3
Bologna 3
Boston 3
Bratislava 3
Budapest 3
Carapicuíba 3
Charlotte 3
Columbia 3
Columbus 3
Cotia 3
Detroit 3
Düsseldorf 3
Fortaleza 3
Goiânia 3
Haiphong 3
Ipatinga 3
Jakarta 3
Totale 2.214
Salva come PNG Salva come JPEG
Nome #
Nanoalgosomes: Introducing extracellular vesicles produced by microalgae 181
Isolation of extracellular vesicles from microalgae: Towards the production of sustainable and natural nanocarriers of bioactive compounds 152
The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach 128
BubbleMumble Lab: un Mobile Serious Game per l'apprendimento dei concetti legati ai processi di estrazione e funzionalizzazione delle vescicole extracellulari 110
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies 102
New landscapes and horizons in hepatocellular carcinoma therapy. 99
BubbleMumble Kart: un Web Serious Game per l'apprendimento dei concetti di base legati alle vescicole extracellulari 95
The Role of Metaphor in Serious Games Design: the BubbleMumble Case Study 95
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 92
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells 79
The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH 78
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma 76
BubbleMumble: A Serious Game for the Dissemination of Scientific Results in Secondary Schools 72
Post-translational lipidation in extracellular vesicles: chemical mechanisms, biological functions and applications 71
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma 70
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 69
COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. 64
Hepatocellular Carcinoma: A Difficult Cancer to Treat 63
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway 62
In vitro and in vivo antitumor activity of the proteasome inhibitor MLN2238 in hepatocellular carcinoma cells 62
VES4US: Extracellular vesicles from a natural source for tailor-made nanomaterials 60
Antioxidant Bioprospecting in Microalgae: Characterisation of the Potential of Two Marine Heterokonts from Irish Waters 60
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells 59
GSK-3 in liver diseases: Friend or foe? 57
Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview 55
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment 54
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 54
Emerging Use of Nanotechnology for the Treatment of Liver Diseases 49
Sialylation of host proteins as targetable risk factor for COVID-19 susceptibility and spreading: A hypothesis 49
Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors 48
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. 44
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 44
The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells 42
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. 40
Calixarene-Based Nanostructures for Delivering Coumarin 6 for Tumor-Cell Imaging and Photoinduced Toxicity 39
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. 39
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. 39
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. 39
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 38
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 37
From targets to targeted therapies in Hepatocellular carcinoma 36
Molecular mechanisms of sorafenib action in liver cancer cells. 36
Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. 35
Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. 35
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. 34
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 34
Cyclooxygenases in cancer 34
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 33
Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) 32
Gene expression profiling of human liver cancer cells following celecoxib treatment. 32
G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 32
A general path for large-scale solubilization of cellular proteins: From membrane receptors to multiprotein complexes. 32
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 32
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 30
Induction of Apoptosis and Inhibition of Cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 30
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. 30
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. 30
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 30
The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism 30
WNT5A Inhibits Hepatocyte Proliferation and Concludes ?-Catenin Signaling in Liver Regeneration 30
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. 30
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. 29
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. 29
Antitumor activity of the novel small molecule Akt inhibitor SC66 in hepatocellular carcinoma cells. 28
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 28
Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? 28
Changes in desmosomal proteins during liver regeneration after mouse partial hepatectomy 27
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells 27
Episodic Ataxia Type 1 mutation F184C alters Zn2+-induced modulation of the human potassium channel Kv1.4-Kv1.1/Kv{beta}1.1. 27
Inhibition of cell growth in human hepatocellular carcinoma cells by selective COX-2 inhibitors 27
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 27
An Episodic Ataxia Type-1 (EA1) mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+ 27
Wnt5a inhibits beta-catenin signaling and proliferation in hepatocyte cultures: Implications in liver regeneration 26
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells 25
Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. 25
Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels 25
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 25
Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production 24
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells 24
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. 22
Non-canonical Wnt signaling during liver regeneration 21
Totale 3.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.888
article - articoli 7.538
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 690
Totale 21.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202424 0 0 0 0 0 0 0 0 1 0 14 9
2024/20251.394 29 8 90 40 282 74 17 87 78 120 315 254
2025/20262.110 94 204 225 364 382 67 255 117 134 125 63 80
2026/2027436 107 96 233 0 0 0 0 0 0 0 0 0
Totale 3.964